DR. JOSHUA LEON NOVACK MD
Prescription History 1215566310
Internal Medicine - Rheumatology in New York, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. JOSHUA LEON NOVACK MD, an active Rheumatology specialist practicing in New York, NY. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 26 documented patient claims. Among these therapy options, the most frequently utilized medication is Methotrexate, which accounts for 14 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Claims | 30-Day Fills | Days Supply | Cost / Claim | Utilization vs NY Avg |
|---|---|---|---|---|---|
| MethotrexateMethotrexate Sodium | 14 | 15.8 | 448 | $24.38▼ below NY avg | ▼ Below Avg. |
Utilization: claims vs the average NY prescriber Averages are among NY prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the NY average This provider's average cost per claim is below the NY average for this medication. 15.8 30-Day Fills 448 Days Supply About Methotrexate: Methotrexate is used to treat certain types of cancer (such as acute lymphoblastic leukemia, non-Hodgkin's lymphoma) or to control severe psoriasis or rheumatoid arthritis that has not responded to other treatments. Show more ▾ It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function. An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. | |||||
| Hydroxychloroquine Sulfate | 12 | 29.4 | 876 | $65.65▼ below NY avg | ▼ Below Avg. |
Utilization: claims vs the average NY prescriber Averages are among NY prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the NY average This provider's average cost per claim is below the NY average for this medication. 29.4 30-Day Fills 876 Days Supply About Hydroxychloroquine Sulfate: Hydroxychloroquine is used to prevent or treat malaria caused by mosquito bites. Show more ▾ The United States Center for Disease Control provides updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world. Discuss the most recent information with your doctor before traveling to areas where malaria occurs. This medication is also used to treat certain auto-immune diseases (lupus, rheumatoid arthritis). It belongs to a class of medications known as disease-modifying antirheumatic drugs (DMARDs). It can reduce skin problems in lupus and prevent swelling/pain in arthritis. Hydroxychloroquine is not recommended for coronavirus infection, also known as COVID-19, unless you are enrolled in a study. Talk to your doctor about the risks and benefits. A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970) | |||||
About this data. The prescription history for DR. JOSHUA LEON NOVACK MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Rheumatology prescribing approach at this New York, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
